Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France-Reference-Cited by-同舟云学术

Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France

Published:2019-09 Issue:4 Volume:74 Page:469-476
ISSN:0040-5957
Container-title:Therapies
language:en
Short-container-title:Therapies

Author:

Bénard-Laribière Anne,Noize Pernelle,Girodet Pierre-Oliver,Lassalle Régis,Dureau-Pournin Caroline,Droz-Perroteau Cécile,Fourrier-Réglat Annie,Salvo Francesco,Bezin Julien,Pariente Antoine

Funder

French Medicines Agency

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference19 articles.

1. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?;Le Jeunne;Therapie,2013

2. The safety of newly approved medicines: do recent market removals mean there is a problem?;Friedman;JAMA,1999

3. Valvular heart disease associated with fenfluramine-phentermine;Connolly;N Engl J Med,1997

4. Ten steps the Federal Government should take now to reverse the opioid addiction epidemic;Kolodny;JAMA,2017

5. Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial;Coffin;PLoS One,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?;Therapies;2023-09

2. An evaluation of the relationship between the occurrence of chronic kidney disease and the use of NSAIDs;Bali Medical Journal;2023-01-05

3. Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis;Biomedicines;2022-11-18

4. Emergence of psychiatric adverse events during antipsychotic treatment in AP-naïve children and adolescents;Child and Adolescent Psychiatry and Mental Health;2022-11-12

5. Potential inappropriate use of strong opioid analgesics in cancer outpatients during the last year of life in France and associated factors;British Journal of Clinical Pharmacology;2021-08-26